Summary
Peri-implant diseases remain one of the most significant long-term threats
to implant success. Early detection, accurate monitoring, and appropriate
intervention are critical, yet clinical approaches remain variable and, at
times, controversial. This presentation will review contemporary concepts
in peri-implant health surveillance, diagnostic tools for early disease
detection, and evidence-based treatment strategies for peri-implantitis,
with particular attention to emerging technologies and adjunctive
therapies.
Presenters
Michael Glogauer, DDS, PhD, Dip Perio, CAHS
Michael is an internationally recognized dental clinician,
scientist, and leader in dentistry, oral immunity, oral diseases,
and the links between oral and systemic health. He completed a
post-doctoral fellowship at Harvard Medical School (1999–2001), has
been a professor in the Faculty of Dentistry, University of Toronto,
since 2002, is Head of Dentistry at the University Health Network,
Chief of Dental Oncology at the Princess Margaret Cancer Centre, and
owner of OMGPerio, a periodontal and dental implant practice in
Hamilton, Ontario. He received the Quality of Life Research Award
from the Canadian Institutes of Health Research (CIHR) – Institute
of Musculoskeletal Health and Arthritis (IMHA) in 2006 and has been
funded by the Medical Research Council of Canada (MRC)/CIHR since
1994. He has published over 280 peer-reviewed papers in dentistry,
oral health, and immunology, holds five patents, and is CEO and
co-founder of the start-up Ostia Sciences, which focuses on oral
microbiome testing and probiotic development. He is also a Fellow of
the Canadian Academy of Health Sciences.
Martha Szczepulski, BDSc(DH), DH, PID (she, her/elle)
Martha is a dedicated dental hygienist, professional educator, and
speaker. Since 2005, she has gained extensive work experience in
general and community dental practices, dental hygiene education,
and mobile dental hygiene in long-term care settings. Currently, she
is the Professional Education Leader at Oral Science, where she
focuses on providing actionable insights for dental clinicians by
bridging the gap between evidence-based practice and practical
common sense. Martha resides in Vancouver, British Columbia, and
enjoys staying active through gym workouts, cycling scenic routes,
and skiing cross-country trails.
Learning Outcomes
After the presentation, participants will be able to:
-
Define peri-implant health, peri-implant mucositis, and
peri-implantitis using current consensus criteria
-
Critically evaluate the benefits and limitations of periodontal
probing around implants
-
Understand the role of PerioMonitor in early detection of
implant-associated inflammation and infection
-
Interpret clinical, immunologic, and microbial markers relevant to
peri-implant disease progression
-
Review the scientific rationale and clinical evidence for Nd:YAG laser
therapy and LAPIP in peri-implantitis management